Navigation Links


PharmaVentures Advises Transgene on the Sale of Their Biopharmaceutical Manufacturing Plant

2/4/2016
OXFORD, England , February 4, 2016 Strasbourg, France , to the US company Advanced Bioscience Laboratories (ABL), Inc. --> Strasbourg, France , to the US company Advanced Bioscience Laboratories (ABL), Inc. --> PharmaVentures is pleased to announce that it acted as an advisor to Transgene on the sale of its biopharmaceutical manufacturing unit in Strasbourg, France... [Comments]

FireflySci Releases Top Rated Custom Glass Cuvette Solution

2/4/2016
Brooklyn, NY (PRWEB) February 04, 2016 Many of the engineers at FireflySci, Inc. have been manufacturing quartz and glass cuvettes for over 10 years. What sets them apart from other cuvette manufacturers is their supercharged customer service and their extensive database of glass cuvette k... [Comments]

ViaCyte Acquires Rights to BetaLogics Assets, Expanding and Extending Industry-Leading Portfolio for Stem Cell-Derived Approaches to Type 1 Diabetes

2/3/2016
SAN DIEGO , Feb. 3, 2016   ViaCyte, Inc ., a leading, privately-held regenerative medicine company with the first pluripotent stem cell-derived islet replacement therapy for the treatment of type 1 diabetes in clinical-stage development, today announced that ViaCyte and Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, have agreed... [Comments]

Discovery Labs Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

2/3/2016
WARRINGTON, Pa. , Feb. 3, 2016  Discovery Laboratories, Inc. (NASDAQ: DSCO ), a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today announced that its Board of Directors has approved an inducement award as a component of employment compensation for Craig Fraser , its newly appointed President and Chief Executiv... [Comments]

Trends in mammalian cell cultures

2/3/2016
LONDON , Feb. 3, 2016  With the growing need for better therapeutics, and the current patent cliff that is underway, therapies such as monoclonal antibodies, recombinant protein therapeutics and even vaccines for a whole host of indications are in high demand. Conventionally expression systems were utilized to aid in the development and production of these therapeutics. Ho... [Comments]

Ascendis Pharma A/S to Present at the Leerink Partners Global Healthcare Conference

2/3/2016
COPENHAGEN, Denmark , Feb. 3, 2016 Ascendis Pharma A/S (Nasdaq: ASND ), a clinical stage biotechnology company that applies its innovative TransCon technology to address significant unmet medical needs, today announced plans to present at an upcoming investor conference.Event:2016 Leerink Partners Global Healthcare Conference Location: Waldorf Astoria, New York, NY Date:... [Comments]

Bioengineered Organ Implant Developer HART to Webcast BIO CEO Conference Presentation Tues., Feb. 9th at 8:00 am EST

2/3/2016
NEW YORK and HOLLISTON, Mass., Feb. 3, 2016 Harvard Apparatus Regenerative Technology, Inc. (Nasdaq: HART ), a biotechnology company developing bioengineered organ implants for life-threatening conditions of the esophagus, trachea and bronchus, today announced that CEO Jim McGorry , will present at the BIO CEO & Investor Conference on Tuesday, February 9, 2016 at... [Comments]

New Jersey Health Foundation Awards $1 Million to Advance Research Throughout NJ

2/3/2016
NEW BRUNSWICK, N.J. , Feb. 3, 2016 New Jersey Health Foundation (NJHF) has awarded 30 grants totaling more than $1 million for researchers in New Jersey who are working on health-related research that demonstrates exciting potential.   James M. Golubieski , this round of funding for the New Jersey Health Foundation Research Grant Program was a... [Comments]

Global Pneumatic Tube System Provider Aerocom Establishes North American Office to Focus on Hospital Market

2/3/2016
Denver, Colorado (PRWEB) February 03, 2016 Aerocom, a world-leading supplier of pneumatic tube systems to hospitals, has established a new office dedicated to the North American healthcare market. Aerocom Healthcare, LLC will be based in Denver, Colo., and will provide turnkey solutions to... [Comments]

ProMIS Neurosciences Announces Identification of a Second Novel Therapeutic Target for Alzheimer’s Disease

2/3/2016
Toronto, ON (PRWEB) February 03, 2016 ProMIS Neurosciences is currently in the process of identifying and validating a series of potential targets (epitopes) specific to misfolded, propagating strains of Amyloid beta involved in Alzheimer’s disease. The Company plans to use these targets to c... [Comments]

[previous] [next]
(Date:2/1/2016)... Feb. 1, 2016  Wocket® smart wallet ( www.wocketwallet.com ) announces the ... Joey Fatone . Las Vegas , where ... --> Las Vegas , where Joey appeared at ... The new video ad was filmed at the Consumer Electronics Show (CES2016) ... Wocket booth to meet and greet fans. --> ...
(Date:1/22/2016)... January 22, 2016 ... addition of the  "Global Behavioral Biometric ... --> http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has ... Behavioral Biometric Market 2016-2020"  report to ... and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced ...
(Date:1/20/2016)... JOSE, Calif. , Jan. 20, 2016 /PRNewswire/ ... developer of human interface solutions, today announced sampling ... controller solution for wearables and small screen applications ... such as printers. Supporting round and rectangular shapes, ... S1423 offers excellent performance with moisture on screen, ...
Breaking Biology News(10 mins):
Recognizes a full-length CLC-2 voltage-gated Cl- protein and not with other known proteins tested so far....
Presenilin 2 Immunogen: Synthetic peptide corresponding to residues 31-47 of human Presenilin 2. Storage: -20 C, Avoid Freeze/Thaw Cycles...
... Rabbit polyclonal to ErbB 2 - ... for all tested applications). ... AENPEYLGLDVPV conjugated to KLH, corresponding to ... Human c-ErbB2 Entrez ...
Recognizes TWIK-2. Does not cross react with any other known proteins....
Biology Products:
(Date:2/4/2016)... New FDA action date of July 22, 2016 ... 22, 2016   --> - New ... - Lifitegrast has the potential to be the only product ... signs and symptoms of dry eye disease in adults --> ... in the U.S. in the past decade indicated for the treatment of signs ...
(Date:2/4/2016)... , Feb. 4, 2016 Beike Biotechnology, the ... medical institutions attended a ceremony in late 2015 to ... cell therapy in 2016. --> ... Translation Platform for Personalized Cell Therapy" was hosted by ... Production Center, both subsidiaries of Beike Biotechnology Co., Ltd. ...
(Date:2/4/2016)... , Feb. 4, 2016 ContraVir Pharmaceuticals, Inc. ... the development and commercialization of targeted antiviral therapies, announced ... Investor Conference 2016, to be held February 8-9, 2016, ... Group,s 2016 Disruptive Growth & Healthcare Conference, taking place ... 10-11, 2016. James Sapirstein , Chief Executive ...
(Date:2/4/2016)... 4, 2016 Strasbourg, France ... --> Strasbourg, France , to the ... PharmaVentures is pleased to announce that it acted as an ... unit in Strasbourg, France , to the ... --> --> Transgene (Euronext: TNG), a member ...
Breaking Biology Technology: